Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Pediatric Infectious Disease Journal|October 19, 2019
Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in ChinaFengcai Zhu, Yuemei Hu, Jingxin Li, et al.
Human Vaccines & Immunotherapeutics|April 13, 2022
Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girlsXingmei Yao, Wengang He, Xianghong Wu, et al.
Human Vaccines & Immunotherapeutics|May 10, 2016
Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trialKai Chu, Jialei Hu, Fanyue Meng, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 24, 2016
[Detection of neutralizing antibodies and DNA of human papillomavirus 16, 18 in women aged 18-45 years in Funing, Jiangsu province]Wenyu Liu, Feixue Wei, Jie Tang, et al.
Human Vaccines & Immunotherapeutics|August 7, 2023
A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of ageKai Chu, Yuemei Hu, Hongxing Pan, et al.
The Pediatric Infectious Disease Journal|June 3, 2016
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in ChinaFengcai Zhu, Yuemei Hu, Jingxin Li, et al.
The Journal of Infectious Diseases|January 13, 2017
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label StudyMingwei Wei, Fanyue Meng, Shiyuan Wang, et al.
Human Vaccines & Immunotherapeutics|April 1, 2017
The early-onset febrile reaction following vaccination and associated factors: An exploratory sub-study based on the Ebola vaccine clinical trialQigang Dai, Qi Liang, Yuemei Hu, et al.
Future Microbiology|July 29, 2022
Comparison of HPV neutralizing and IgG antibodies in unvaccinated female adolescentsXingmei Yao, Kai Chu, Jun Zhao, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 yearsFengcai Zhu, Juan Li, Yuemei Hu, et al.
Pageof 5